Estrogen receptor-mediated long-range chromatin interactions and transcription in breast cancer

Molecular and Cellular Endocrinology

Volumn 382, Issue 1, 2014, Pages 624-632

  Liu, Mei Hui ^a,b   Cheung, Edwin ^b  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b GENOME INSTITUTE OF SINGAPORE   (Singapore)

Author keywords

3C; ChIA PET; Distal regulation; Estrogen receptor ; Long range chromatin interaction

Indexed keywords

ESTROGEN RECEPTOR ALPHA;

BREAST CANCER; CANCER CELL; CANCER GENETICS; CHROMATIN; CHROMATIN STRUCTURE; GENE EXPRESSION REGULATION; GENE INTERACTION; GENE MAPPING; GENETIC TRANSCRIPTION; GENOME; GENOME ANALYSIS; HISTONE MODIFICATION; HUMAN; LONG RANGE CHROMATIN INTERACTION; NEOPLASM; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; REVIEW;

3C; CHIA-PET; DISTAL REGULATION; ESTROGEN RECEPTOR-Α; LONG-RANGE CHROMATIN INTERACTION;

BREAST NEOPLASMS; CHROMATIN; ESTROGEN RECEPTOR ALPHA; FEMALE; HUMANS; MODELS, BIOLOGICAL; TRANSCRIPTION, GENETIC;

EID: 84888333482     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2013.09.019     Document Type: Review

References (94)

1. Ahmadiyeh N., Pomerantz M.M., Grisanzio C., Herman P., Jia L., Almendro V., He H.H., Brown M., Liu X.S., Davis M., et al. 8q24 prostate, breast, and colon cancer risk loci show tissue-specific long-range interaction with MYC. Proc. Natl. Acad. Sci. USA 2010, 107:9742-9746.
2. Barnett D.H., Sheng S., Charn T.H., Waheed A., Sly W.S., Lin C.Y., Liu E.T., Katzenellenbogen B.S. Estrogen receptor regulation of carbonic anhydrase XII through a distal enhancer in breast cancer. Cancer Res. 2008, 68:3505-3515.
3. Bhat-Nakshatri P., Wang G., Appaiah H., Luktuke N., Carroll J.S., Geistlinger T.R., Brown M., Badve S., Liu Y., Nakshatri H. AKT alters genome-wide estrogen receptor alpha binding and impacts estrogen signaling in breast cancer. Mol. Cell. Biol. 2008, 28:7487-7503.
4. Boney-Montoya J., Ziegler Y.S., Curtis C.D., Montoya J.A., Nardulli A.M. Long-range transcriptional control of progesterone receptor gene expression. Mol. Endocrinol. 2009.
5. Bretschneider N., Kangaspeska S., Seifert M., Reid G., Gannon F., Denger S. E2-mediated cathepsin D (CTSD) activation involves looping of distal enhancer elements. Mol. Oncol. 2008, 2:182-190.
6. Cai S., Lee C.C., Kohwi-Shigematsu T. SATB1 packages densely looped, transcriptionally active chromatin for coordinated expression of cytokine genes. Nat. Genet. 2006, 38:1278-1288.
7. Carroll J.S., Liu X.S., Brodsky A.S., Li W., Meyer C.A., Szary A.J., Eeckhoute J., Shao W., Hestermann E.V., Geistlinger T.R., et al. Chromosome-wide mapping of estrogen receptor binding reveals long-range regulation requiring the forkhead protein FoxA1. Cell 2005, 122:33-43.
8. Carroll J.S., Meyer C.A., Song J., Li W., Geistlinger T.R., Eeckhoute J., Brodsky A.S., Keeton E.K., Fertuck K.C., Hall G.F., et al. Genome-wide analysis of estrogen receptor binding sites. Nat. Genet. 2006, 38:1289-1297.
9. Chan C.S., Song J.S. CCCTC-binding factor confines the distal action of estrogen receptor. Cancer Res. 2008, 68:9041-9049.
10. Chepelev I., Wei G., Wangsa D., Tang Q., Zhao K. Characterization of genome-wide enhancer-promoter interactions reveals co-expression of interacting genes and modes of higher order chromatin organization. Cell Res. 2012, 22:490-503.
11. Cheung E., Kraus W.L. Genomic analyses of hormone signaling and gene regulation. Annu. Rev. Physiol. 2010, 72:191-218.
12. Core L.J., Waterfall J.J., Lis J.T. Nascent RNA sequencing reveals widespread pausing and divergent initiation at human promoters. Science 2008, 322:1845-1848.
13. Cowper-Sal lari R., Zhang X., Wright J.B., Bailey S.D., Cole M.D., Eeckhoute J., Moore J.H., Lupien M. Breast cancer risk-associated SNPs modulate the affinity of chromatin for FOXA1 and alter gene expression. Nat. Genet. 2012, 44:1191-1198.
14. Cullen K.E., Kladde M.P., Seyfred M.A. Interaction between transcription regulatory regions of prolactin chromatin. Science 1993, 261:203-206.
15. de Leeuw R., Flach K., Bentin Toaldo C., Alexi X., Canisius S., Neefjes J., Michalides R., Zwart W. PKA phosphorylation redirects ERalpha to promoters of a unique gene set to induce tamoxifen resistance. Oncogene 2012.
16. de Wit E., de Laat W. A decade of 3C technologies: insights into nuclear organization. Genes Dev. 2012, 26:11-24.
17. Dejardin J., Kingston R.E. Purification of proteins associated with specific genomic Loci. Cell 2009, 136:175-186.
18. Dekker J., Rippe K., Dekker M., Kleckner N. Capturing chromosome conformation. Science 2002, 295:1306-1311.
19. Demare L.E., Leng J., Cotney J., Reilly S.K., Yin J., Sarro R., Noonan J.P. The genomic landscape of cohesin-associated chromatin interactions. Genome Res. 2013, 23:1224-1234.
20. Deng W., Lee J., Wang H., Miller J., Reik A., Gregory P.D., Dean A., Blobel G.A. Controlling long-range genomic interactions at a native locus by targeted tethering of a looping factor. Cell 2012, 149:1233-1244.
21. Deschenes J., Bourdeau V., White J.H., Mader S. Regulation of GREB1 transcription by estrogen receptor alpha through a multipartite enhancer spread over 20kb of upstream flanking sequences. J. Biol. Chem. 2007, 282:17335-17339.
22. Dietz S.C., Carroll J.S. Interrogating the genome to understand oestrogen-receptor-mediated transcription. Expert Rev. Mol. Med. 2008, 10:e10.
23. Dixon J.R., Selvaraj S., Yue F., Kim A., Li Y., Shen Y., Hu M., Liu J.S., Ren B. Topological domains in mammalian genomes identified by analysis of chromatin interactions. Nature 2012, 485:376-380.
24. Dostie J., Richmond T.A., Arnaout R.A., Selzer R.R., Lee W.L., Honan T.A., Rubio E.D., Krumm A., Lamb J., Nusbaum C., et al. Chromosome conformation capture carbon copy (5C): a massively parallel solution for mapping interactions between genomic elements. Genome Res. 2006, 16:1299-1309.
25. Edelman L.B., Fraser P. Transcription factories: genetic programming in three dimensions. Curr. Opin. Genet. Dev. 2012, 22:110-114.
26. Ethier S.D., Miura H., Dostie J. Discovering genome regulation with 3C and 3C-related technologies. Biochim. Biophys. Acta 2012, 1819:401-410.
27. Fullwood M.J., Liu M.H., Pan Y.F., Liu J., Xu H., Mohamed Y.B., Orlov Y.L., Velkov S., Ho A., Mei P.H., et al. An oestrogen-receptor-alpha-bound human chromatin interactome. Nature 2009, 462:58-64.
28. Gee J.M., Eloranta J.J., Ibbitt J.C., Robertson J.F., Ellis I.O., Williams T., Nicholson R.I., Hurst H.C. Overexpression of TFAP2C in invasive breast cancer correlates with a poorer response to anti-hormone therapy and reduced patient survival. J. Pathol. 2009, 217:32-41.
29. Gondor A., Rougier C., Ohlsson R. High-resolution circular chromosome conformation capture assay. Nat. Protoc. 2008, 3:303-313.
30. Hah N., Danko C.G., Core L., Waterfall J.J., Siepel A., Lis J.T., Kraus W.L. A rapid, extensive, and transient transcriptional response to estrogen signaling in breast cancer cells. Cell 2011, 145:622-634.
31. Hah N., Murakami S., Nagari A., Danko C.G., Kraus W.L. Enhancer transcripts mark active estrogen receptor binding sites. Genome Res. 2013, 23:1210-1223.
32. Hakim O., Misteli T. SnapShot: chromosome confirmation capture. Cell 2012, 148(1068). pp. e1061-1062.
33. Handoko L., Xu H., Li G., Ngan C.Y., Chew E., Schnapp M., Lee C.W., Ye C., Ping J.L., Mulawadi F., et al. CTCF-mediated functional chromatin interactome in pluripotent cells. Nat. Genet. 2011, 43:630-638.
34. Hewitt S.C., Li L., Grimm S.A., Chen Y., Liu L., Li Y., Bushel P.R., Fargo D., Korach K.S. Research resource: whole-genome estrogen receptor alpha binding in mouse uterine tissue revealed by ChIP-seq. Mol. Endocrinol. 2012, 26:887-898.
35. Holmes K.A., Hurtado A., Brown G.D., Launchbury R., Ross-Innes C.S., Hadfield J., Odom D.T., Carroll J.S. Transducin-like enhancer protein 1 mediates estrogen receptor binding and transcriptional activity in breast cancer cells. Proc. Natl. Acad. Sci. USA 2012, 109:2748-2753.
36. Hsu P.Y., Hsu H.K., Singer G.A., Yan P.S., Rodriguez B.A., Liu J.C., Weng Y.I., Deatherage D.E., Chen Z., Pereira J.S., et al. Estrogen-mediated epigenetic repression of large chromosomal regions through DNA looping. Genome Res. 2010, 20:733-744.
37. Hu Q., Kwon Y.S., Nunez E., Cardamone M.D., Hutt K.R., Ohgi K.A., Garcia-Bassets I., Rose D.W., Glass C.K., Rosenfeld M.G., et al. Enhancing nuclear receptor-induced transcription requires nuclear motor and LSD1-dependent gene networking in interchromatin granules. Proc. Natl. Acad. Sci. USA 2008, 105:19199-19204.
38. Hurtado A., Holmes K.A., Geistlinger T.R., Hutcheson I.R., Nicholson R.I., Brown M., Jiang J., Howat W.J., Ali S., Carroll J.S. Regulation of ERBB2 by oestrogen receptor-PAX2 determines response to tamoxifen. Nature 2008, 456:663-666.
39. Jozwik K.M., Carroll J.S. Pioneer factors in hormone-dependent cancers. Nat. Rev. Cancer 2012, 12:381-385.
40. Kocanova S., Kerr E.A., Rafique S., Boyle S., Katz E., Caze-Subra S., Bickmore W.A., Bystricky K. Activation of estrogen-responsive genes does not require their nuclear co-localization. PLoS Genet. 2010, 6:e1000922.
41. Kong S.L., Li G., Loh S.L., Sung W.K., Liu E.T. Cellular reprogramming by the conjoint action of ERalpha, FOXA1, and GATA3 to a ligand-inducible growth state. Mol. Syst. Biol. 2011, 7:526.
42. Kosak S.T., Skok J.A., Medina K.L., Riblet R., Le Beau M.M., Fisher A.G., Singh H. Subnuclear compartmentalization of immunoglobulin loci during lymphocyte development. Science 2002, 296:158-162.
43. Krum S.A., Miranda-Carboni G.A., Lupien M., Eeckhoute J., Carroll J.S., Brown M. Unique ERalpha cistromes control cell type-specific gene regulation. Mol. Endocrinol. 2008, 22:2393-2406.
44. Kwon Y.S., Garcia-Bassets I., Hutt K.R., Cheng C.S., Jin M., Liu D., Benner C., Wang D., Ye Z., Bibikova M., et al. Sensitive ChIP-DSL technology reveals an extensive estrogen receptor alpha-binding program on human gene promoters. Proc. Natl. Acad. Sci. USA 2007, 104:4852-4857.
45. Lai F., Orom U.A., Cesaroni M., Beringer M., Taatjes D.J., Blobel G.A., Shiekhattar R. Activating RNAs associate with Mediator to enhance chromatin architecture and transcription. Nature 2013, 494:497-501.
46. Li G., Ruan X., Auerbach R.K., Sandhu K.S., Zheng M., Wang P., Poh H.M., Goh Y., Lim J., Zhang J., et al. Extensive promoter-centered chromatin interactions provide a topological basis for transcription regulation. Cell 2012, 148:84-98.
47. Li W., Notani D., Ma Q., Tanasa B., Nunez E., Chen A.Y., Merkurjev D., Zhang J., Ohgi K., Song X., et al. Functional roles of enhancer RNAs for oestrogen-dependent transcriptional activation. Nature 2013, 498:516-520.
48. Lieberman-Aiden E., van Berkum N.L., Williams L., Imakaev M., Ragoczy T., Telling A., Amit I., Lajoie B.R., Sabo P.J., Dorschner M.O., et al. Comprehensive mapping of long-range interactions reveals folding principles of the human genome. Science 2009, 326:289-293.
49. Lin C.Y., Vega V.B., Thomsen J.S., Zhang T., Kong S.L., Xie M., Chiu K.P., Lipovich L., Barnett D.H., Stossi F., et al. Whole-genome cartography of estrogen receptor alpha binding sites. PLoS Genet. 2007, 3:e87.
50. Ling J.Q., Li T., Hu J.F., Vu T.H., Chen H.L., Qiu X.W., Cherry A.M., Hoffman A.R. CTCF mediates interchromosomal colocalization between Igf2/H19 and Wsb1/Nf1. Science 2006, 312:269-272.
51. Liu Y., Gao H., Marstrand T.T., Strom A., Valen E., Sandelin A., Gustafsson J.A., Dahlman-Wright K. The genome landscape of ERalpha- and ERbeta-binding DNA regions. Proc. Natl. Acad. Sci. USA 2008, 105:2604-2609.
52. Lupien M., Meyer C.A., Bailey S.T., Eeckhoute J., Cook J., Westerling T., Zhang X., Carroll J.S., Rhodes D.R., Liu X.S., et al. Growth factor stimulation induces a distinct ER(alpha) cistrome underlying breast cancer endocrine resistance. Genes Dev. 2010, 24:2219-2227.
53. Magnani L., Ballantyne E.B., Zhang X., Lupien M. PBX1 genomic pioneer function drives ERalpha signaling underlying progression in breast cancer. PLoS Genet. 2011, 7:e1002368.
54. Mani R.S., Tomlins S.A., Callahan K., Ghosh A., Nyati M.K., Varambally S., Palanisamy N., Chinnaiyan A.M. Induced chromosomal proximity and gene fusions in prostate cancer. Science 2009, 326:1230.
55. Maston G.A., Landt S.G., Snyder M., Green M.R. Characterization of enhancer function from genome-wide analyses. Annu. Rev. Genomics Hum. Genet. 2012, 13:29-57.
56. McEwan M.V., Eccles M.R., Horsfield J.A. Cohesin is required for activation of MYC by estradiol. PLoS ONE 2012, 7:e49160.
57. Melo C.A., Drost J., Wijchers P.J., van de Werken H., de Wit E., Oude Vrielink J.A., Elkon R., Melo S.A., Leveille N., Kalluri R., et al. ERNAs are required for p53-dependent enhancer activity and gene transcription. Mol. Cell 2013, 49:524-535.
58. Misteli T. Higher-order genome organization in human disease. Cold Spring Harb. Perspect. Biol. 2010, 2:a000794.
59. Mohammed H., D'Santos C., Serandour A.A., Ali H.R., Brown G.D., Atkins A., Rueda O.M., Holmes K.A., Theodorou V., Robinson J.L., et al. Endogenous purification reveals GREB1 as a key estrogen receptor regulatory factor. Cell Rep. 2013, 3:342-349.
60. Natoli G., Andrau J.C. Noncoding transcription at enhancers: general principles and functional models. Annu. Rev. Genet. 2012, 46:1-19.
61. Orom U.A., Derrien T., Beringer M., Gumireddy K., Gardini A., Bussotti G., Lai F., Zytnicki M., Notredame C., Huang Q., et al. Long noncoding RNAs with enhancer-like function in human cells. Cell 2010, 143:46-58.
62. Orom U.A., Derrien T., Guigo R., Shiekhattar R. Long noncoding RNAs as enhancers of gene expression. Cold Spring Harb. Symp. Quant. Biol. 2010, 75:325-331.
63. Pan Y.F., Wansa K.D., Liu M.H., Zhao B., Hong S.Z., Tan P.Y., Lim K.S., Bourque G., Liu E.T., Cheung E. Regulation of estrogen receptor-mediated long range transcription via evolutionarily conserved distal response elements. J. Biol. Chem. 2008, 283:32977-32988.
64. Perillo B., Ombra M.N., Bertoni A., Cuozzo C., Sacchetti S., Sasso A., Chiariotti L., Malorni A., Abbondanza C., Avvedimento E.V. DNA oxidation as triggered by H3K9me2 demethylation drives estrogen-induced gene expression. Science 2008, 319:202-206.
65. Phillips J.E., Corces V.G. CTCF: master weaver of the genome. Cell 2009, 137:1194-1211.
66. Phillips-Cremins J.E., Sauria M.E., Sanyal A., Gerasimova T.I., Lajoie B.R., Bell J.S., Ong C.T., Hookway T.A., Guo C., Sun Y., et al. Architectural protein subclasses shape 3D organization of genomes during lineage commitment. Cell 2013, 153:1281-1295.
67. Pomerantz M.M., Ahmadiyeh N., Jia L., Herman P., Verzi M.P., Doddapaneni H., Beckwith C.A., Chan J.A., Hills A., Davis M., et al. The 8q24 cancer risk variant rs6983267 shows long-range interaction with MYC in colorectal cancer. Nat. Genet. 2009, 41:882-884.
68. Ragoczy T., Bender M.A., Telling A., Byron R., Groudine M. The locus control region is required for association of the murine beta-globin locus with engaged transcription factories during erythroid maturation. Genes Dev. 2006, 20:1447-1457.
69. Remeseiro S., Losada A. Cohesin, a chromatin engagement ring. Curr. Opin. Cell Biol. 2013, 25:63-71.
70. Ross-Innes C.S., Stark R., Holmes K.A., Schmidt D., Spyrou C., Russell R., Massie C.E., Vowler S.L., Eldridge M., Carroll J.S. Cooperative interaction between retinoic acid receptor-alpha and estrogen receptor in breast cancer. Genes Dev. 2010, 24:171-182.
71. Ross-Innes C.S., Brown G.D., Carroll J.S. A co-ordinated interaction between CTCF and ER in breast cancer cells. BMC Genomics 2011, 12:593.
72. Sajan S.A., Hawkins R.D. Methods for identifying higher-order chromatin structure. Annu. Rev. Genomics Hum. Genet. 2012, 13:59-82.
73. Sandhu K.S., Li G., Poh H.M., Quek Y.L., Sia Y.Y., Peh S.Q., Mulawadi F.H., Lim J., Sikic M., Menghi F., et al. Large-scale functional organization of long-range chromatin interaction networks. Cell Rep. 2012, 2:1207-1219.
74. Sanyal A., Lajoie B.R., Jain G., Dekker J. The long-range interaction landscape of gene promoters. Nature 2012, 489:109-113.
75. Schmidt D., Schwalie P.C., Ross-Innes C.S., Hurtado A., Brown G.D., Carroll J.S., Flicek P., Odom D.T. A CTCF-independent role for cohesin in tissue-specific transcription. Genome Res. 2010, 20:578-588.
76. Schoenfelder S., Sexton T., Chakalova L., Cope N.F., Horton A., Andrews S., Kurukuti S., Mitchell J.A., Umlauf D., Dimitrova D.S., et al. Preferential associations between co-regulated genes reveal a transcriptional interactome in erythroid cells. Nat. Genet. 2010, 42:53-61.
77. Serandour A.A., Avner S., Oger F., Bizot M., Percevault F., Lucchetti-Miganeh C., Palierne G., Gheeraert C., Barloy-Hubler F., Peron C.L., et al. Dynamic hydroxymethylation of deoxyribonucleic acid marks differentiation-associated enhancers. Nucleic Acids Res. 2012, 40:8255-8265.
78. Simonis M., Klous P., Splinter E., Moshkin Y., Willemsen R., de Wit E., van Steensel B., de Laat W. Nuclear organization of active and inactive chromatin domains uncovered by chromosome conformation capture-on-chip (4C). Nat. Genet. 2006, 38:1348-1354.
79. Solovei I., Cremer M. 3D-FISH on cultured cells combined with immunostaining. Methods Mol. Biol. 2010, 659:117-126.
80. Tan S.K., Lin Z.H., Chang C.W., Varang V., Chng K.R., Pan Y.F., Yong E.L., Sung W.K., Cheung E. AP-2gamma regulates oestrogen receptor-mediated long-range chromatin interaction and gene transcription. EMBO J. 2011, 30:2569-2581.
81. Theodorou V., Stark R., Menon S., Carroll J.S. GATA3 acts upstream of FOXA1 in mediating ESR1 binding by shaping enhancer accessibility. Genome Res. 2013, 23:12-22.
82. Tiwari V.K., Cope L., McGarvey K.M., Ohm J.E., Baylin S.B. A novel 6C assay uncovers Polycomb-mediated higher order chromatin conformations. Genome Res. 2008, 18:1171-1179.
83. van Berkum N.L., Dekker J. Determining spatial chromatin organization of large genomic regions using 5C technology. Methods Mol. Biol. 2009, 567:189-213.
84. Wang D., Garcia-Bassets I., Benner C., Li W., Su X., Zhou Y., Qiu J., Liu W., Kaikkonen M.U., Ohgi K.A., et al. Reprogramming transcription by distinct classes of enhancers functionally defined by eRNA. Nature 2011, 474:390-394.
85. Welboren W.J., van Driel M.A., Janssen-Megens E.M., van Heeringen S.J., Sweep F.C., Span P.N., Stunnenberg H.G. ChIP-Seq of ERalpha and RNA polymerase II defines genes differentially responding to ligands. EMBO J. 2009, 28:1418-1428.
86. Wendt K.S., Yoshida K., Itoh T., Bando M., Koch B., Schirghuber E., Tsutsumi S., Nagae G., Ishihara K., Mishiro T., et al. Cohesin mediates transcriptional insulation by CCCTC-binding factor. Nature 2008, 451:796-801.
87. Woodfield G.W., Horan A.D., Chen Y., Weigel R.J. TFAP2C controls hormone response in breast cancer cells through multiple pathways of estrogen signaling. Cancer Res. 2007, 67:8439-8443.
88. Wright J.B., Brown S.J., Cole M.D. Upregulation of c-MYC in cis through a large chromatin loop linked to a cancer risk-associated single-nucleotide polymorphism in colorectal cancer cells. Mol. Cell. Biol. 2010, 30:1411-1420.
89. Wurtele H., Chartrand P. Genome-wide scanning of HoxB1-associated loci in mouse ES cells using an open-ended chromosome conformation capture methodology. Chromosome Res. 2006, 14:477-495.
90. Zaret K.S., Carroll J.S. Pioneer transcription factors: establishing competence for gene expression. Genes Dev. 2011, 25:2227-2241.
91. Zhang Y., Liang J., Li Y., Xuan C., Wang F., Wang D., Shi L., Zhang D., Shang Y. CCCTC-binding factor acts upstream of FOXA1 and demarcates the genomic response to estrogen. J. Biol. Chem. 2010, 285:28604-28613.
92. Zhang Z., Chang C.W., Goh W.L., Sung W.K., Cheung E. CENTDIST: discovery of co-associated factors by motif distribution. Nucleic Acids Res. 2011, 39. pp. W391-399.
93. Zhang Y., McCord R.P., Ho Y.J., Lajoie B.R., Hildebrand D.G., Simon A.C., Becker M.S., Alt F.W., Dekker J. Spatial organization of the mouse genome and its role in recurrent chromosomal translocations. Cell 2012, 148:908-921.
94. Zhao Z., Tavoosidana G., Sjolinder M., Gondor A., Mariano P., Wang S., Kanduri C., Lezcano M., Sandhu K.S., Singh U., et al. Circular chromosome conformation capture (4C) uncovers extensive networks of epigenetically regulated intra- and interchromosomal interactions. Nat. Genet. 2006, 38:1341-1347.